CPRX vs TM · P/E 18, rev $491.7M vs P/E 9.7, rev $234.60B
Catalyst Pharmaceuticals Inc (CPRX) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the CPRX and TM stock pages for the full models.
Not investment advice.